Blu – Pagina 91

Marzo 28, 2024 dario.olivero

Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study

Suzuki Y, Kaneko H, Nagasawa H, et al.
Diabetes Obes Metab. Pub. Online 26 Mar 2024.

Leggi

Marzo 28, 2024 dario.olivero

Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study

Eroglu TE, Coronel R, Souverein PC
Eur Heart J Cardiovasc Pharmacother. 2024;pvae022.

Leggi

Marzo 25, 2024 dario.olivero

Treatment Intensification following Glucagon-Like Peptide-1 Receptor Agonist in Type 2 Diabetes: Comparative Effectiveness Analyses Between Free vs. Fixed combination of GLP-1 RA and Basal Insulin. RESTORE-G Real-World Study

Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R on behalf of the RESTORE-G (Retrospective analysis on the therapeutic approches after GLP1-RA treatment in type 2 diabetes patients) Study Group
Nutr Metab Cardiovasc Dis. Pub. online 23 Mar 2024.

Leggi

Marzo 25, 2024 dario.olivero

Efficacy and safety of tirzepatide in overweight and obese adult patients with type 1 diabetes

Garg SK, Akturk HK, Kaur G, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.

Leggi

Marzo 25, 2024 dario.olivero

Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression

Rivera FB, Lumbang GNO, Gaid DRM, et al.
Diabetes Obes Metab. Pub. online 20 Mar 2024.

Leggi

Marzo 25, 2024 dario.olivero

Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study

Zhou BG, Xia JL, Jiang X, et al.
BMC Endocr Disord. 2024;24(1):40.

Leggi

Marzo 25, 2024 dario.olivero

Associations between hypoglycemia awareness status and symptoms of hypoglycemia among adults with type 1 or insulin-treated type 2 diabetes using the Hypo-METRICS smartphone application

Martine-Edith G, Zaremba N, Divilly P, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.

Leggi

Marzo 25, 2024 dario.olivero

Prevalence of distal symmetrical polyneuropathy by diabetes prevention program treatment group, diabetes status, duration of diabetes, and cumulative glycemic exposure

Lee CG, Ciarleglio A, Edelstein SL, et al.
Diabetes Care. 2024;dc232009.

Leggi

Marzo 25, 2024 dario.olivero

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes

Bell DSH, Jerkins T
Diabetes Obes Metab. Pub. online 22 Mar 2024.

Leggi

Marzo 22, 2024 dario.olivero

An automated insulin delivery system with automatic meal bolus based on a hand-gesturing algorithm

Roy A, Grosman B, Benedetti A, et al.
Diabetes Technol Ther. Pub. online 12 Mar 2024.

Leggi